Literature DB >> 24560594

Cross-talk between liver and intestine in control of cholesterol and energy homeostasis.

Albert K Groen1, Vincent W Bloks2, Henkjan Verkade2, Folkert Kuipers2.   

Abstract

A major hurdle for organisms to dispose of cholesterol is the inability to degrade the sterol nucleus which constitutes the central part of the molecule. Synthesis of the sterol nucleus requires a complex, energy costly, metabolic pathway but also generates a diverse array of intermediates serving crucial roles in cellular energy metabolism and signal transduction. This may be the reason why this complex pathway has survived evolutionary pressure. The only way to get rid of substantial amounts of cholesterol is conversion into bile acid or direct excretion of the sterol in the feces. The lack of versatility in disposal mechanisms causes a lack of flexibility to regulate cholesterol homeostasis which may underlie the considerable human pathology linked to cholesterol removal from the body. Export of cholesterol from the body requires an intricate communication between intestine and the liver. The last decade this inter-organ cross talk has been focus of intense research leading to considerable new insight. This novel information on particular the cross-talk between liver and intestine and role of bile acids as signal transducing molecules forms the focus of this review.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha-muricholate (PubChem CID: 53477700); Beta-muricholate (PubChem CID: 5283853); Bile acids; Chenodeoxycholate (PubChem CID: 10133); Cholate(PubChem CID: 221493); Cholestasis; Cholesterol (PubChem CID: 5997); FGF15; GW4064 (PubChem CID: 9893571); HMGCoA (PubChem CID: 439218); Mevalonate (PubChem CID: 5288798); PC (PubChem CID: 45266626); Reverse cholesterol transport; SM (PubChem CID: 70678679); TICE; Transintestinal cholesterol excretion; Ubiquinone (PubChem CID: 5281915)

Mesh:

Substances:

Year:  2014        PMID: 24560594     DOI: 10.1016/j.mam.2014.02.001

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  7 in total

Review 1.  Intestinal nuclear receptors in HDL cholesterol metabolism.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  J Lipid Res       Date:  2014-07-28       Impact factor: 5.922

2.  Liver and the defects of cholesterol and bile acids biosynthesis: Rare disorders many diagnostic pitfalls.

Authors:  Gaetano Corso; Antonio Dello Russo; Monica Gelzo
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

3.  Mulberry Fruit Extract Promotes Serum HDL-Cholesterol Levels and Suppresses Hepatic microRNA-33 Expression in Rats Fed High Cholesterol/Cholic Acid Diet.

Authors:  Soojin Lee; Mak-Soon Lee; Eugene Chang; Yoonjin Lee; Jaerin Lee; Jiyeon Kim; Chong-Tai Kim; In-Hwan Kim; Yangha Kim
Journal:  Nutrients       Date:  2020-05-21       Impact factor: 5.717

4.  High hydrostatic pressure extract of mulberry leaves ameliorates hypercholesterolemia via modulating hepatic microRNA-33 expression and AMPK activity in high cholesterol diet fed rats.

Authors:  Eunyoung Lee; Mak-Soon Lee; Eugene Chang; Chong-Tai Kim; Ae-Jin Choi; In-Hwan Kim; Yangha Kim
Journal:  Food Nutr Res       Date:  2021-05-03       Impact factor: 3.894

5.  Depletion of Gut Microbiota Inhibits Hepatic Lipid Accumulation in High-Fat Diet-Fed Mice.

Authors:  Hui Han; Mengyu Wang; Ruqing Zhong; Bao Yi; Martine Schroyen; Hongfu Zhang
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

6.  Effects of Cigarette Smoke Exposure on the Gut Microbiota and Liver Transcriptome in Mice Reveal Gut-Liver Interactions.

Authors:  Lei Meng; Mengjun Xu; Youwen Xing; Chen Chen; Jiandong Jiang; Xihui Xu
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

Review 7.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.